| Abstract | OBJECTIVE: To assess the efficacy of 1-h plasma glucose concentration and the metabolic syndrome in predicting future risk of type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 1,611 subjects from the San Antonio Heart Study, who were free of type 2 diabetes at baseline; who had plasma glucose and insulin concentrations measured at time 0, 30, 60, and 120 min during the oral glucose tolerance test (OGTT); and who had their diabetes status determined with an OGTT after 7-8 years of follow-up, were evaluated. Two models, based on glucose tolerance status, 1-h plasma glucose concentration, and presence of the metabolic syndrome, were tested in predicting the risk for type 2 diabetes at 7-8 years of follow-up. RESULTS: A cutoff point of 155 mg/dl for the 1-h plasma glucose concentration during the OGTT was used to stratify subjects in each glucose tolerance group into low, intermediate, and high risk for future type 2 diabetes. A model based upon 1-h plasma glucose concentration, Adult Treatment Panel (ATP) III criteria for the metabolic syndrome, and fasting plasma glucose, independent of 2-h plasma glucose, performed equally well in stratifying nondiabetic subjects into low, intermediate, and high risk for future type 2 diabetes and identified a group of normal glucose-tolerant subjects who were at very high risk for future type 2 diabetes. CONCLUSIONS: The plasma glucose concentration at 1 h during the OGTT is a strong predictor of future risk for type 2 diabetes. A plasma glucose cutoff point of 155 mg/dl and the ATP III criteria for the metabolic syndrome can be used to stratify nondiabetic subjects into three risk groups: low, intermediate, and high risk. |
| Authors | Muhammad A Abdul-Ghani, Tamam Abdul-Ghani, Nibal Ali, Ralph A Defronzo
(Affiliation: Divisions of Diabetes and Epidemiology, University of Texas Health Science Center at San Antonio, Texas, USA. abdulghani at uthscsa.edu)
|
| Journal | Diabetes care
(Diabetes Care)
Vol. 31
Issue 8
Pg. 1650-5
(Aug 2008)
ISSN: 1935-5548 [Electronic] United States |
| PMID | 18487478
(Publication Type: Journal Article)
|
| Chemical References |
|
| Topics |
- Adult
- Blood Glucose
(metabolism)
- Body Mass Index
- Body Size
- Diabetes Mellitus, Type 2
(epidemiology)
- Fasting
- Female
- Glucose Tolerance Test
- Humans
- Male
- Metabolic Syndrome X
(blood, complications)
- Middle Aged
- Risk Factors
- Texas
(epidemiology)
|